Gara Jalqabaatti › Infeekshinii COVID-19 fi Koronavaayirasii
Qorannoo klinikaalii Infeekshinii COVID-19 fi Koronavaayirasii Ameerikaa Keessatti hirmaatuu
Qorannoo 24 Infeekshinii COVID-19 fi Koronavaayirasii f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Washington, DCQorannoo 7
- Durham, NCQorannoo 5
- Houston, TXQorannoo 5
- Boston, MAQorannoo 5
- Dallas, TXQorannoo 5
- Atlanta, GAQorannoo 5
- Los Angeles, CAQorannoo 4
- New York City, NYQorannoo 4
- Hialeah, FLQorannoo 4
- San Francisco, CAQorannoo 3
- Chicago, ILQorannoo 3
- Pittsburgh, PAQorannoo 3
- Seattle, WAQorannoo 3
- Cincinnati, OHQorannoo 3
- Mountain View, CAQorannoo 3
- Baltimore, MDQorannoo 3
- Boise, IDQorannoo 3
- Salt Lake City, UTQorannoo 3
Naannoon
- AlabamaQorannoo 3
- CaliforniaQorannoo 12
- ColoradoQorannoo 4
- Distaarikii KoloombiyaaQorannoo 3
- FloridaQorannoo 6
- GeorgiaQorannoo 6
- IdahoQorannoo 3
- IllinoisQorannoo 5
- KentuckyQorannoo 3
- MarylandQorannoo 8
- MassachusettsQorannoo 5
- MichiganQorannoo 4
- MinnesotaQorannoo 3
- New YorkQorannoo 6
- North CarolinaQorannoo 5
- OhioQorannoo 7
- PennsylvaniaQorannoo 5
- South CarolinaQorannoo 3
- TennesseeQorannoo 3
- TexasQorannoo 9
- UtahQorannoo 4
- VirginiaQorannoo 4
- WashingtonQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 7 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04448145A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07536308Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05624450A Study of COVID-19 Vaccine(s) in Children and Adults
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
Umuriin 5 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07798648A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06631287A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06679140Viral Infections in Healthy and Immunocompromised Hosts
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
6 Months – 120 Years · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT01306084Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT04772170Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 0 hanga 20 · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT04278404A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 40 hanga 64 · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06810934Respiratory Virus Sampling and Repository
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 3 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05266222A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Namoota walitti qabaa jiraSadarkaa 4Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT07730450Long-term Impact of Infection With Novel Coronavirus (COVID-19)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 23-Ado-2026 · NCT04362150COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 24-Wax-2026 · NCT04391816Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Namoota walitti qabaa jiraSadarkaa 3
Umuriin hundi · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT03808922Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Wax-2026 · NCT01904188Impact of the Coronavirus (COVID-19) on Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 27-Elb-2026 · NCT04330521ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Elb-2026 · NCT04367857A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Namoota walitti qabaa jiraSadarkaa 4Hojjettoota fayyaa simatamoo
6 Months · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT06585241Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 9 hanga 64 · Saalaa hunda · Haaromfame 18-Bit-2026 · NCT04579588Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 05-Ful-2025 · NCT05868239Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Cam-2021 · NCT04445285Clazakizumab vs. Placebo - COVID-19 Infection
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2020 · NCT04494724Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.